» Articles » PMID: 23965236

The MOnitoring Resynchronization DEvices and CARdiac PatiEnts (MORE-CARE) Randomized Controlled Trial: Phase 1 Results on Dynamics of Early Intervention with Remote Monitoring

Abstract

Background: Remote monitoring (RM) in patients with advanced heart failure and cardiac resynchronization therapy defibrillators (CRT-D) may reduce delays in clinical decisions by transmitting automatic alerts. However, this strategy has never been tested specifically in this patient population, with alerts for lung fluid overload, and in a European setting.

Objective: The main objective of Phase 1 (presented here) is to evaluate if RM strategy is able to reduce time from device-detected events to clinical decisions.

Methods: In this multicenter randomized controlled trial, patients with moderate to severe heart failure implanted with CRT-D devices were randomized to a Remote group (with remote follow-up and wireless automatic alerts) or to a Control group (with standard follow-up without alerts). The primary endpoint of Phase 1 was the delay between an alert event and clinical decisions related to the event in the first 154 enrolled patients followed for 1 year.

Results: The median delay from device-detected events to clinical decisions was considerably shorter in the Remote group compared to the Control group: 2 (25(th)-75(th) percentile, 1-4) days vs 29 (25(th)-75(th) percentile, 3-51) days respectively, P=.004. In-hospital visits were reduced in the Remote group (2.0 visits/patient/year vs 3.2 visits/patient/year in the Control group, 37.5% relative reduction, P<.001). Automatic alerts were successfully transmitted in 93% of events occurring outside the hospital in the Remote group. The annual rate of all-cause hospitalizations per patient did not differ between the two groups (P=.65).

Conclusions: RM in CRT-D patients with advanced heart failure allows physicians to promptly react to clinically relevant automatic alerts and significantly reduces the burden of in-hospital visits.

Trial Registration: Clinicaltrials.gov NCT00885677; http://clinicaltrials.gov/show/NCT00885677 (Archived by WebCite at http://www.webcitation.org/6IkcCJ7NF).

Citing Articles

Recent Advances in Cardiac Resynchronization Therapy: Current Treatment and Future Direction.

Siddiqui A, Tasouli-Drakou V, Ringor M, DiCaro M, Yee B, Lei K J Clin Med. 2025; 14(3).

PMID: 39941560 PMC: 11818169. DOI: 10.3390/jcm14030889.


A systematic review of the impacts of remote patient monitoring (RPM) interventions on safety, adherence, quality-of-life and cost-related outcomes.

Tan S, Sumner J, Wang Y, Yip A NPJ Digit Med. 2024; 7(1):192.

PMID: 39025937 PMC: 11258279. DOI: 10.1038/s41746-024-01182-w.


Contemporary Advances in Cardiac Remote Monitoring: A Comprehensive, Updated Mini-Review.

Preda A, Falco R, Tognola C, Carbonaro M, Vargiu S, Gallazzi M Medicina (Kaunas). 2024; 60(5).

PMID: 38793002 PMC: 11122881. DOI: 10.3390/medicina60050819.


Validation of a Heart Failure Risk Score in a Cohort of Cardiac Resynchronization Therapy Patients Under Remote Monitoring: Results from the TriageHF™ Algorithm.

Cardoso I, Silva Cunha P, Laranjo S, Grazina A, Miguel Viegas J, Portugal G J Innov Card Rhythm Manag. 2023; 14(9):5576-5581.

PMID: 37781719 PMC: 10540879. DOI: 10.19102/icrm.2023.14093.


Integration of a Smartphone HF-Dedicated App in the Remote Monitoring of Heart Failure Patients with Cardiac Implantable Electronic Devices: Patient Access, Acceptance, and Adherence to Use.

Ziacchi M, Molon G, Giudici V, Botto G, Viscusi M, Brasca F J Clin Med. 2023; 12(17).

PMID: 37685593 PMC: 10488122. DOI: 10.3390/jcm12175528.


References
1.
Yu C, Wang L, Chau E, Chan R, Kong S, Tang M . Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005; 112(6):841-8. DOI: 10.1161/CIRCULATIONAHA.104.492207. View

2.
Boriani G, Diemberger I, Martignani C, Biffi M, Valzania C, Bertini M . Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives. J Gen Intern Med. 2008; 23 Suppl 1:73-7. PMC: 2150639. DOI: 10.1007/s11606-007-0355-5. View

3.
Boriani G, Gasparini M, Landolina M, Lunati M, Proclemer A, Lonardi G . Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy. Eur J Heart Fail. 2011; 13(8):868-76. DOI: 10.1093/eurjhf/hfr046. View

4.
Van Veldhuisen D, Maass A . Telemonitoring of outpatients with heart failure: a search for the holy grail?. Circulation. 2012; 125(24):2965-7. DOI: 10.1161/CIRCULATIONAHA.112.118141. View

5.
Lazarus A . Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing Clin Electrophysiol. 2007; 30 Suppl 1:S2-S12. DOI: 10.1111/j.1540-8159.2007.00595.x. View